Skip to Content

Vibegron Dosage

Medically reviewed by Drugs.com. Last updated on Feb 16, 2021.

Applies to the following strengths: 75 mg

Usual Adult Dose for Overactive Bladder Syndrome

75 mg orally once a day

Use: For the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults

Renal Dose Adjustments

Mild (CrCl 60-89 mL/min), moderate (CrCl 30-59 mL/min), and severe renal dysfunction (CrCl less than 30 mL/min): No adjustment recommended.

End-stage renal disease (CrCl <15 mL/min): Not recommended.

Liver Dose Adjustments

Mild to moderate liver dysfunction (Child-Pugh Classes A to B): No adjustment recommended.

Severe liver dysfunction (Child-Pugh Class C): Not recommended.

Precautions

CONTRAINDICATIONS:
-Hypersensitivity to the active substance or to any of the excipients.

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration advice:
-Tablets can be swallowed whole or crushed and mixed with a tablespoon of applesauce and taken immediately with a glass of water.
-This drug can be given with or without food.

Storage Requirements:
-Store at 20C to 25C (68F to 77F), excursions permitted to 15C to 30C (59F to 86F).

Monitoring:
-Renal: Urinary retention

Patient advice:
-Advise the patient to read the approved patient labeling.
-Advise patients to inform their healthcare provider if they experience symptoms consistent with urinary retention.

More about vibegron

Consumer resources

Other brands
Gemtesa

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.